Preliminary simulations [BE/BA News]

posted by ElMaestro  – Denmark, 2022-04-30 21:10 (326 d 05:38 ago) – Posting: # 22946
Views: 1,901

Hi Hötzi,

your post is potentially highly significant.

❝ Is this really the intention? The wider the range in tmax, the more easily products will pass. Counterintuitive.


The intention, as I understand it, was exactly the opposite. It goes completely against all intention, doesn't it?
I think this knowledge, if it holds in confirmatory simulations, should be published quickly and made available to regulators.

I very much hope that regulators will abstain completely from letting pride prevail over the regard for the EU patient. So I hope they will not dismiss the argumentation. For example, I could fear they would dismiss your findings because they don't have a palate for simulations (but note they like simulations well enough when it comes to f2; bootstrapping is a simulation, too).

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
22,548 posts in 4,723 threads, 1,606 registered users;
18 visitors (0 registered, 18 guests [including 12 identified bots]).
Forum time: 01:48 CET (Europe/Vienna)

You can’t really say “similar” if it’s the same again you want.
“Similar” means something different.    Anthony Burgess

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5